<unk>  is an androgen receptor inhibitor that is FDA approved for the treatment of non-metastatic castration-resistant prostate cancer.   Common adverse reactions include fatigue, hypertension, rash, diarrhea, nausea, weight decreased, arthralgia, fall, hot flush, decreased appetite, fracture, and peripheral edema.
Apalutamide
Bicalutamide
Nilutamide
Flutamide
Carbutamide
Enzalutamide
Tamoxifen
Anastrozole